2. Academic Validation
  3. Design, synthesis, and evaluation of mupirocin prodrugs restoring systemic efficacy against MRSA

Design, synthesis, and evaluation of mupirocin prodrugs restoring systemic efficacy against MRSA

  • Eur J Med Chem. 2026 Feb 5:303:118406. doi: 10.1016/j.ejmech.2025.118406.
Zhi Gong 1,  Ruixue Zhang 1,  Linpu Yang 1,  Hongzhi Gong 1,  Chao Huang 1,  Xiaohong Yang 2,  Haibo Peng 3,  Yun He 4
Affiliations

Affiliations

  • 1 School of Pharmaceutical Sciences, Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Chongqing University, Chongqing, 401331, PR China.
  • 2 Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing, 400714, PR China. Electronic address: yangxiaohong@cigit.ac.cn.
  • 3 Chongqing Academy of Science and Technology, Chongqing, 401123, PR China. Electronic address: phaibo2024@163.com.
  • 4 School of Pharmaceutical Sciences, Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Chongqing University, Chongqing, 401331, PR China; Translational Innovation Center, Shenzhen Bay Laboratory, Shenzhen, 518132, PR China. Electronic address: yun.he@cqu.edu.cn.
PMID: 41317683 DOI: 10.1016/j.ejmech.2025.118406
Abstract

The promising Antibiotic mupirocin suffers from rapid enzymatic degradation in plasma, characterized by an extremely short half-life, which strictly limits its use to topical applications. To overcome this pharmacokinetic limitation, we rationally designed mupirocin prodrugs targeting its carboxylic acid with enzymatically cleavable ester linkers. The synthesis was achieved through a selective esterification reaction of the mupirocin's carboxyl group with various lipophilic moieties. All newly synthesized prodrug candidates were fully characterized using 1H NMR, 13C NMR, and HRMS. The lead compound 3d, featuring a cholesterol-disulfide linker, demonstrated optimized pharmacokinetic properties with a 6-fold extended plasma half-life and a remarkable 1356-fold greater pulmonary area under the concentration-time curve (AUC) compared to mupirocin. In both systemic and neutropenic murine lung Infection models, 3d exhibited potent anti-MRSA efficacy (50-100 mg/kg). This study validates the prodrug approach as a viable strategy to unlock the systemic therapeutic potential of mupirocin against Bacterial infections.

Keywords

Antibiotics; MRSA infections; Mupirocin; Pharmacokinetics; Prodrugs.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z